The shape of things to come - Cleveland's top tech tips for 2014
This article was originally published in Clinica
Executive Summary
Are the conditions for innovative device uptake getting any more favorable? US hospital group Cleveland Clinic believes so, in spite of the much-opposed device sales tax still being in place, ever-increasing regulation, and M&A and investment activity still stuck in the slow lane – the completed IPOs for LDR and Tandem Diabetes providing some uplift in the US medical devices field in 2013.